March 26, 2020 / 8:11 AM / 5 days ago

BRIEF-Sareum Holdings Signs Global Licensing Deal With China-Based Specialty Pharma Company

March 26 (Reuters) - Sareum Holdings PLC:

* SAREUM SIGNS GLOBAL LICENSING DEAL FOR ITS FLT3+AURORA KINASE INHIBITOR PROGRAMME WITH A CHINA-BASED SPECIALTY PHARMA COMPANY

* WILL RECEIVE AN INITIAL UPFRONT PAYMENT OF APPROXIMATELY £50,000 & FURTHER PAYMENT OF ABOUT £0.9 MILLION ON CERTAIN MILESTONES MET Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below